General Information |
| Board Constituency: |
Foundation |
| Organization Type - Primary: |
Foundation |
| Organization Type - Secondary: |
Private Foundation |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
International |
| Organization Description: |
| LHL International was established in January 2013 by the Norwegian Heart and Lung Patient Association (LHL). LHL International will continue and further develope LHLs work against TB. LHL was originally establisehd as an organisation by and for people living with TB in 1943. LHL International works internationally and nationally. |
| |
| Total number of staff in your organization: |
6 - 10 |
| Number of full-time staff who are directly involved with TB: |
6 - 10 |
| Number of part-time staff who are directly involved with TB: |
1 - 5 |
| Number of volunteers who are directly involved with TB: |
6 - 10 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
$1 MIL-$10 MIL |
| How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: |
Network with other partners |
| |
| Are you a member of a Stop TB national partnership: |
No |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| LHL International is a member of the National TB control committee. LHL International is e.g. the only organisation developing information material on TB in Norway and we are working closely with the Norwegian health system on TB (training, information etc). |
| |
Geographical Reach |
| Which country is your headquarters located in: |
Norway |
| Which WHO region is the main focus of your work: |
African |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Malawi Nepal |
Contribution |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
DOTS Expansion and Enhancement: We are working on DOTS expansion and Enhancement in Malawi, Zambia, Sudan, Tanzania, Russia and Nepal through partners such as NTP, reasearch organisations and patient organisations. We contribute with funding and technical advise.
Drug-Resistant TB: In Russia and Nepal in particular, through partners.We contribute with funding and technical advise.
TB-HIV: We are working on DOTS expansion and Enhancement in Malawi, Zambia, Sudan, Tanzania, Russia and Nepal through partners such as NTP, reasearch organisations and patient organisations. We contribute with funding and technical advise.
New TB Vaccines: Advocacy, in particular towards Norwegian authorities. We cooperate with Aeras.
Operational Research: In particular in Malawi and Sudan by supporting Reach Trust and Epi-lab. We also cooperate with Liverpool School of Tropical Medicine. |